METHOD FOR PREDICTING DYSPLASTIC COXARTHROSIS DEVELOPMENT COURSE BY DETERMINING OSTEOTROPIC CALCITONIN HORMONE LEVEL IN BLOOD SERUM
FIELD: medicine. ^ SUBSTANCE: method involves determining content of osteotropic calcitonin hormone of direct action in blood serum. The value being equal to 5 pkg/ml, non-progressing dysplastic coxarthrosis development course is predicted. The value being equal to or greater than 6 pkg/ml, progress...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine. ^ SUBSTANCE: method involves determining content of osteotropic calcitonin hormone of direct action in blood serum. The value being equal to 5 pkg/ml, non-progressing dysplastic coxarthrosis development course is predicted. The value being equal to or greater than 6 pkg/ml, progressive disease development course is predicted. ^ EFFECT: enhanced accuracy of prognosis when no reliable X-ray or clinical data are available. |
---|